KYNTRA BIO, INC.
Ownership & governance
Executives 5Directors 5Avg age 63Avg tenure 7.2y
TW
Thane Wettig
Chief Executive Officer
Age 61Since 2023-07-22Profile →
+9
Executives5
Board of directors5
Shareholders5
| Name | Stake | Shares |
|---|---|---|
| Armistice Capital LLC | 9.881 % | 400,000 |
| Vanguard Capital Management LLC | 3.869 % | 156,607 |
| Acadian Asset Management LLC | 2.608 % | 105,585 |
| BlackRock Institutional Trust Co. NA | 2.083 % | 84,331 |
| Two Sigma Investments LP | 1.223 % | 49,511 |
Catalog · 2026-07-09
Registry officers10
| Name | Role | Since | Shares |
|---|---|---|---|
| David DeLucia | Director of Finance/CFO | 2024-12-15 | - |
| Elias Kouchakji | Chief Tech/Sci/R&D Officer | 2013-12-31 | - |
| James Schoeneck | Chairman | 2020-01-05 | - |
| Thane Wettig | Chief Executive Officer | 2023-07-22 | - |
| Jeffrey Edwards | Director/Board Member | 2015-10-27 | - |
| May Kin Ho | Director/Board Member | 2018-12-05 | - |
| Michael Kauffman | Director/Board Member | 2025-06-03 | - |
| Thane Wettig | Director/Board Member | 2023-10-01 | - |
Registry · as of 2026-07-09
Institutional (13F)
Loading Form 13F holders…
Fund membership
Loading fund baskets…
Street consensus
Consensus buyMean target 38.5Range 35–43Analysts 4
35Mean 38.543
- Strong buy 1
- Buy 3
- Hold 1
Broker actions7
| Firm | Action | To | Target | Date |
|---|---|---|---|---|
| Maxim Group | Initiated | Buy | 35 | 2026-10-13 |
| Lake Street | Initiated | Buy | 41 | 2026-09-17 |
| HC Wainwright & Co. | Reiterated | Buy | 43 | 2026-09-01 |
| Oppenheimer | Initiated | Outperform | 35 | 2026-07-07 |
| Rodman & Renshaw | Initiated | Buy | 30 | 2026-06-09 |
| HC Wainwright & Co. | Reiterated | Buy | 43 | 2025-09-24 |
| HC Wainwright & Co. | Maintained | Buy | 43 | 2025-08-07 |
Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.